Clinical Trials Browser

Phase 1 × INDUSTRY × emactuzumab × Clear all

NCT02323191 2020-08-27

A Study of Emactuzumab and Atezolizumab Administered in Combination in Participants With Advanced Solid Tumors

Phase 1 Completed

Solid Cancers

NCT02760797 2018-05-22

A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid Tumors

Phase 1 Completed

Neoplasms

NCT03369964 2018-04-05

A Study of Atezolizumab in Combination With an Immunotherapy Agent Investigated With or Without Anti-Cd20 Therapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Phase 1 Withdrawn

Lymphoma, Non-Hodgkin

NCT01494688 2018-03-16

A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors